DeepMed Research

VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Use of MRI and CTBS for Catatonia in Autism

Phase 1

Recruiting

Conditions: Autism Spectrum Disorder
Catatonia
Intellectual Disability

Interventions: Device: Continuous Theta Burst in Transcranial Magnetic Stimulation

First Posted Date: 2023-08-30

Last Posted Date: 2025-01-09

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 40

Registration Number: NCT06016764

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated with Radioactive Iodine for Thyroid Cancer

Phase 3

Recruiting

Conditions: Nasolacrimal Duct Obstruction
Thyroid Cancer

Interventions: Drug: Artificial Tears Methylcellulose

First Posted Date: 2023-08-21

Last Posted Date: 2024-10-26

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 100

Registration Number: NCT05999630

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Attentional Mechanisms in SCD

Early Phase 1

Not yet recruiting

Conditions: Subjective Cognitive Decline

Interventions: Drug: Mecamylamine Challenge
Other: Placebo Comparator Challenge

First Posted Date: 2023-08-21

Last Posted Date: 2025-05-13

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 80

Registration Number: NCT06002477

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia

Phase 4

Recruiting

Conditions: Pain
Analgesia
Abuse Opioids

Interventions: Drug: Buccal Placebo
Drug: Buccal Buprenorphine 300 mcg
Drug: Buccal Buprenorphine 600 mcg
Drug: Buccal Buprenorphine 900 mcg
Drug: Oral Placebo
Drug: Buccal Buprenorphine 450mcg
Drug: Oral immediate-release oxycodone 10mg

First Posted Date: 2023-08-14

Last Posted Date: 2024-12-12

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 72

Registration Number: NCT05988710

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function

Phase 1

Recruiting

Conditions: Metabolic Syndrome
Obesity

Interventions: Drug: Empagliflozin 25 MG
Drug: Placebo

First Posted Date: 2023-08-02

Last Posted Date: 2024-11-07

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 74

Registration Number: NCT05972564

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Use of Hand-held Dynamometry to Obtain Objective Measures of Lower Extremity Force Production With Chronic Stroke

Recruiting

Conditions: Weakness, Muscle
Chronic Stroke

First Posted Date: 2023-07-12

Last Posted Date: 2025-05-14

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 20

Registration Number: NCT05941962

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Estamos Juntos (We Are Together): Improving HIV Care Delivery by Capacitating Health Care Providers

Not Applicable

Completed

Conditions: Hiv

Interventions: Behavioral: behavioral therapy and education

First Posted Date: 2023-07-10

Last Posted Date: 2025-05-13

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 29143

Registration Number: NCT05938621

Locations: 🇲🇿
Ministry of Health, Quelimane, Zambezia, Mozambique

Neurophysiology Biomarkers of Cognitive Impairment Associated with Deep Brain Stimulation

Not Applicable

Recruiting

Conditions: Parkinson Disease

Interventions: Device: Neural recordings and stimulation

First Posted Date: 2023-07-06

Last Posted Date: 2025-03-19

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 160

Registration Number: NCT05933681

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Combined Electric and Acoustic Hearing (EAS) in Children and Adults

Not Applicable

Recruiting

Conditions: Cochlear Implant
Hearing Loss

Interventions: Other: Electric and acoustic stimulation (EAS) technology in the implanted ear(s)-this is the combination of a cochlear implant (CI) and hearing aid (HA) in the implanted ear(s)

First Posted Date: 2023-06-28

Last Posted Date: 2025-04-24

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 160

Registration Number: NCT05923203

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
University Of Texas at Austin, Austin, Texas, United States
🇺🇸
University Of Wisconsin Madison, Madison, Wisconsin, United States

Polyethylene-glycol Assisted Nerve Repair in Phalloplasty

Phase 2

Conditions: Gender Dysphoria

Interventions: Drug: Polyethylene Glycol 3350

First Posted Date: 2023-06-09

Last Posted Date: 2024-10-02

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 30

Registration Number: NCT05897086

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy